135 related articles for article (PubMed ID: 7515024)
1. Ectopic expression of c-kit in small-cell lung cancer.
Hida T; Ueda R; Sekido Y; Hibi K; Matsuda R; Ariyoshi Y; Sugiura T; Takahashi T; Takahashi T
Int J Cancer Suppl; 1994; 8():108-9. PubMed ID: 7515024
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of the c-kit and stem cell factor genes in breast carcinomas.
Hines SJ; Organ C; Kornstein MJ; Krystal GW
Cell Growth Differ; 1995 Jun; 6(6):769-79. PubMed ID: 7545433
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene.
Sekido Y; Takahashi T; Ueda R; Takahashi M; Suzuki H; Nishida K; Tsukamoto T; Hida T; Shimokata K; Zsebo KM
Cancer Res; 1993 Apr; 53(7):1709-14. PubMed ID: 7680956
[TBL] [Abstract][Full Text] [Related]
4. Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form.
Miyazawa K; Williams DA; Gotoh A; Nishimaki J; Broxmeyer HE; Toyama K
Blood; 1995 Feb; 85(3):641-9. PubMed ID: 7530502
[TBL] [Abstract][Full Text] [Related]
5. Early CD34high cells can be separated into KIThigh cells in which transforming growth factor-beta (TGF-beta) downmodulates c-kit and KITlow cells in which anti-TGF-beta upmodulates c-kit.
Sansilvestri P; Cardoso AA; Batard P; Panterne B; Hatzfeld A; Lim B; Lévesque JP; Monier MN; Hatzfeld J
Blood; 1995 Sep; 86(5):1729-35. PubMed ID: 7544639
[TBL] [Abstract][Full Text] [Related]
6. Expression of stem cell factor and c-kit in human neuroblastoma. The Children's Cancer Group.
Cohen PS; Chan JP; Lipkunskaya M; Biedler JL; Seeger RC
Blood; 1994 Nov; 84(10):3465-72. PubMed ID: 7524740
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta 1 inhibits expression of the gene products for steel factor and its receptor (c-kit).
Heinrich MC; Dooley DC; Keeble WW
Blood; 1995 Apr; 85(7):1769-80. PubMed ID: 7535588
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-kit and kit ligand in human colon carcinoma cells.
Toyota M; Hinoda Y; Takaoka A; Makiguchi Y; Takahashi T; Itoh F; Imai K; Yachi A
Tumour Biol; 1993; 14(5):295-302. PubMed ID: 7694350
[TBL] [Abstract][Full Text] [Related]
9. Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue.
Strohmeyer T; Reese D; Press M; Ackermann R; Hartmann M; Slamon D
J Urol; 1995 Feb; 153(2):511-5. PubMed ID: 7529338
[TBL] [Abstract][Full Text] [Related]
10. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
[TBL] [Abstract][Full Text] [Related]
11. Characterization of cultured mast cells derived from Ws/Ws mast cell-deficient rats with a small deletion at tyrosine kinase domain of c-kit.
Tei H; Kasugai T; Tsujimura T; Adachi S; Furitsu T; Tohya K; Kimura M; Zsebo KM; Newlands GF; Miller HR
Blood; 1994 Feb; 83(4):916-25. PubMed ID: 7509212
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of erythroid differentiation by stem cell factor in K562 cells expressing the c-kit gene.
Ogawa K; Tashima M; Toi T; Sawai H; Sawada H; Fujita J; Maruyama Y; Okuma M
Exp Hematol; 1994 Jan; 22(1):45-51. PubMed ID: 7506674
[TBL] [Abstract][Full Text] [Related]
13. Transformation of thyroid epithelium is associated with loss of c-kit receptor.
Natali PG; Berlingieri MT; Nicotra MR; Fusco A; Santoro E; Bigotti A; Vecchio G
Cancer Res; 1995 Apr; 55(8):1787-91. PubMed ID: 7536131
[TBL] [Abstract][Full Text] [Related]
14. Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors.
Turner AM; Zsebo KM; Martin F; Jacobsen FW; Bennett LG; Broudy VC
Blood; 1992 Jul; 80(2):374-81. PubMed ID: 1378316
[TBL] [Abstract][Full Text] [Related]
15. Effects of stem cell factor on the growth and radiation survival of tumor cells.
Shui C; Khan WB; Leigh BR; Turner AM; Wilder RB; Knox SJ
Cancer Res; 1995 Aug; 55(15):3431-7. PubMed ID: 7542170
[TBL] [Abstract][Full Text] [Related]
16. The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melanogenesis in Wsh and Ph mutant mice.
Duttlinger R; Manova K; Berrozpe G; Chu TY; DeLeon V; Timokhina I; Chaganti RS; Zelenetz AD; Bachvarova RF; Besmer P
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3754-8. PubMed ID: 7537375
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta regulates c-kit message stability and cell-surface protein expression in hematopoietic progenitors.
Dubois CM; Ruscetti FW; Stankova J; Keller JR
Blood; 1994 Jun; 83(11):3138-45. PubMed ID: 7514900
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors.
Inoue M; Kyo S; Fujita M; Enomoto T; Kondoh G
Cancer Res; 1994 Jun; 54(11):3049-53. PubMed ID: 7514496
[TBL] [Abstract][Full Text] [Related]
19. Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts.
Rygaard K; Nakamura T; Spang-Thomsen M
Br J Cancer; 1993 Jan; 67(1):37-46. PubMed ID: 7678980
[TBL] [Abstract][Full Text] [Related]
20. Steel factor supports the cycling of isolated human CD34+ cells in the absence of other growth factors.
Gore SD; Amin S; Weng LJ; Civin CI
Exp Hematol; 1995 May; 23(5):413-21. PubMed ID: 7536683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
